https://biotechmorning.com/news/cdc-covid-vaccine-study-blocked Biotech Morning en 2026-07-01T14:29:40.472Z The CDC Had Proof COVID Vaccines Work. Someone Buried It. https://biotechmorning.com/news/moderna-bird-flu-vaccine-phase-3-trial Biotech Morning en 2026-07-01T14:28:50.152Z Moderna's Bird Flu Vaccine Just Aced Its Biggest Test Yet https://biotechmorning.com/news/sobi-gout-drug-fda-rejection-manufacturing Biotech Morning en 2026-07-01T14:27:58.124Z Sobi's Gout Drug Works Great. The FDA Still Said No. https://biotechmorning.com/news/ema-revokes-amgen-tavneos-data-integrity Biotech Morning en 2026-07-01T14:27:04.880Z Europe Just Pulled the Plug on an Amgen Drug. The Reason Is Unprecedented. https://biotechmorning.com/news/china-first-solid-tumor-car-t-approval Biotech Morning en 2026-07-01T14:26:14.928Z The Cancer Treatment That Was Never Supposed to Work Just Got Approved https://biotechmorning.com/news/fda-gene-therapy-brain-drain-getting-worse Biotech Morning en 2026-07-01T14:25:22.700Z The FDA's Gene Therapy Brain Drain Is Getting Worse https://biotechmorning.com/news/biogen-850m-china-tj-biopharma-felzartamab-deal Biotech Morning en 2026-07-01T14:24:30.389Z Biogen Just Spent $850M to Bet Big on China. Here's Why. https://biotechmorning.com/news/moderna-flu-covid-combo-vaccine-eu-approval Biotech Morning en 2026-07-01T14:23:36.649Z One Shot to Rule Them All: Europe's Bet on a Flu-COVID Combo Vaccine https://biotechmorning.com/news/fda-precheck-pilot-program-first-cohort Biotech Morning en 2026-07-01T14:22:41.349Z The FDA Just Gave 7 Companies a Backstage Pass to Drug Approval https://biotechmorning.com/news/fda-fired-3000-now-hiring-2200-back Biotech Morning en 2026-07-01T14:21:44.273Z The FDA Fired Thousands of People. Now It's Hiring 2,200 Back. https://biotechmorning.com/news/merck-abbvie-china-clinical-trials-national-security-probe Biotech Morning en 2026-07-01T14:20:56.725Z When Your Drug Trial Lands You in a Pentagon Briefing https://biotechmorning.com/news/ai-scientist-builds-biotech-companies Biotech Morning en 2026-06-30T14:26:41.512Z The AI That Builds Biotech Companies While You Sleep https://biotechmorning.com/news/biocryst-shuts-down-internal-discovery Biotech Morning en 2026-06-30T14:25:46.513Z BioCryst Just Blew Up Its Own Lab https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-cell-therapy Biotech Morning en 2026-06-30T14:24:53.763Z Merck KGaA Just Wrote an $11.3 Billion Check for the Cell Therapy Picks and Shovels https://biotechmorning.com/news/parabilis-medicines-record-biotech-ipo Biotech Morning en 2026-06-30T14:23:57.130Z The Biotech IPO That Just Dethroned Moderna https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-panel-endorsement Biotech Morning en 2026-06-30T14:23:03.354Z Moderna's Flu Shot Just Cleared Its Biggest Hurdle. Now the Real Fight Begins. https://biotechmorning.com/news/enspryng-thyroid-eye-disease-at-home-injection Biotech Morning en 2026-06-30T14:22:08.996Z The Eye Disease Drug That Wants to Ditch the IV Pole https://biotechmorning.com/news/vistagen-anxiety-drug-phase-3-failures Biotech Morning en 2026-06-30T14:21:17.556Z Vistagen's Anxiety Drug Just Went 1-for-3 in Phase 3. Now What? https://biotechmorning.com/news/fda-running-on-fumes-biotech-paying-price Biotech Morning en 2026-06-30T14:20:19.552Z The FDA Is Running on Fumes, and Biotech Is Paying the Price https://biotechmorning.com/news/fda-precheck-pilot-manufacturing-reviews Biotech Morning en 2026-06-30T14:19:26.343Z The FDA Wants to Review Your Factory Before You Even Build It https://biotechmorning.com/news/boulevard-bio-1-6-billion-trispecific-tce-deal Biotech Morning en 2026-06-30T14:18:41.616Z A $1.6 Billion Bet on a Drug That Doesn't Exist Yet